These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6128185)

  • 21. Pharmacologic prophylaxis of supraventricular tachyarrhythmias after coronary artery bypass.
    Dorovenis SA; Weiner B
    Pharmacotherapy; 1996; 16(4):615-8. PubMed ID: 8840367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of atrial fibrillation after cardiac surgery.
    Rho RW
    Heart; 2009 Mar; 95(5):422-9. PubMed ID: 19218267
    [No Abstract]   [Full Text] [Related]  

  • 23. [The secondary prevention of coronary disease: ACE inhibitors, adrenergic beta-blockers and statins for everyone? The arguments con].
    Simões L; Guimarães J; Fontes JP
    Rev Port Cardiol; 2000 Jan; 19(1):107-13. PubMed ID: 10731796
    [No Abstract]   [Full Text] [Related]  

  • 24. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study.
    Izhar U; Ad N; Rudis E; Milgalter E; Korach A; Viola N; Levi E; Asraff G; Merin G; Elami A
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):401-6. PubMed ID: 15678052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New-onset postoperative atrial fibrillation: a riddle wrapped in a mystery inside an enigma.
    Saltman AE
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):311-3. PubMed ID: 14762334
    [No Abstract]   [Full Text] [Related]  

  • 26. [Frequent errors in the therapy of heart disease].
    Heinecker R
    Wien Med Wochenschr; 1982 Nov; 132(22):531-6. PubMed ID: 6132496
    [No Abstract]   [Full Text] [Related]  

  • 27. Coronary risk factors 6-12 months after coronary artery bypass grafting. Comparison of surveys in 1986, 1990 and 1994.
    Simons LA; Simons J; Parfitt A
    Med J Aust; 1994 Nov; 161(9):536-7. PubMed ID: 7968753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vascular surgery associated with aorto-coronary bypass].
    Lubatti L; Turio G; Anguissola GB; Cristofori GB; Brancato B
    Minerva Anestesiol; 1983; 49(1-2):53-6. PubMed ID: 6132351
    [No Abstract]   [Full Text] [Related]  

  • 29. [Need for a long-term program in the follow-up of anti-lipid treatment following coronary artery surgery?].
    Israelsson B; Stagmo M; Alm C; Cline C; Westin L; Willenheimer R; Carlsson R
    Nord Med; 1995; 110(8-9):221-3. PubMed ID: 7478973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1983 Apr; 127(16):673-9. PubMed ID: 6134240
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
    Baumgart P
    MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of sudden death in patients with coronary artery disease.
    Bloom JM
    N Engl J Med; 2000 Apr; 342(17):1291-2. PubMed ID: 10787334
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study.
    Cardona F; Seide H; Cox RA; Pérez CM
    P R Health Sci J; 2003 Jun; 22(2):119-23. PubMed ID: 12866134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Does diabetes change the anti-ischemic therapeutic options in the symptomatic coronary patient?].
    Bory M
    Arch Mal Coeur Vaiss; 2000 Dec; 93 Spec No 4():45-50. PubMed ID: 11296462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk predictors and secondary prevention after PTCA and bypass operations].
    Gulba DC; Waigand J; Osterziel KJ; Dietz R
    Internist (Berl); 1995 Sep; 36(9):891-901. PubMed ID: 7591614
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary prevention of coronary heart disease in women.
    Rees M; Stevenson J;
    Menopause Int; 2008 Mar; 14(1):40-5. PubMed ID: 18380961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary prevention of coronary heart disease in the elderly.
    Dornbrook-Lavender KA; Pieper JA; Roth MT
    Ann Pharmacother; 2003 Nov; 37(11):1654-63. PubMed ID: 14565805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of coronary artery disease in the elderly].
    Rajala S; Haavisto M; Mattila K
    Duodecim; 1988; 104(7):526-31. PubMed ID: 3049024
    [No Abstract]   [Full Text] [Related]  

  • 40. [Secondary prevention after an acute myocardial infarct. Adrenergic beta-blockers, angiotensin-converting enzyme inhibitors and statins for everyone?].
    Morais J
    Rev Port Cardiol; 2000 Jan; 19(1):99-105. PubMed ID: 10731795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.